{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:27:34Z","timestamp":1787772454455,"version":"build-2784847793"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"\n BACKGROUND INFORMATION:<\/jats:title>\n Many institutes have implemented a strict antimicrobial stewardship (AMS) program in the postantibiotic era.<\/jats:p>\n <\/jats:sec>\n \n AIM:<\/jats:title>\n To investigate how the resistance pattern changes after implementation of a stringent AMS programme.<\/jats:p>\n <\/jats:sec>\n \n METHODOLOGY:<\/jats:title>\n It employs a defined daily dose methodology (DDD). The formulae listed below are used to compute this for two periods: October 2015 to October 2017 (Period 1) and October 2017 to October 2019 (Period 2) (Period 2).<\/jats:p>\n DDD = Antibiotics used in total (g) per year<\/jats:p>\n The length of stay was determined using the data from the hospital's information system (HIS). The patterns of resistance to the limited antibiotics are vancomycin, linezolid, tigecycline, and colistin. In both Periods 1 and 2, skin and soft-tissue infections, urinary tract infections, bloodstream infections, and respiratory tract infections were studied in both periods.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n \n In the year from October 2015 to October 2017, 4569 patients received limited antibiotics out of a total of 14,544 admissions. The average length of stay was 7.48 days in Period 1, however, it was reduced to 3.96 days in Period 2 out of 15,199 patients.\n In vitro<\/jats:italic>\n isolate sensitivities to vancomycin, linezolid, tigecycline, and colistin were increased.\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSION:<\/jats:title>\n Some of the most common antibiotics were used less frequently. This appears to be linked to a shorter stay in the hospital and increased antibiotic susceptibility.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijp.ijp_466_20","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T15:48:56Z","timestamp":1716479336000},"page":"253-257","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A retrospective review of a 2-year strong antimicrobial stewardship program in a tertiary care institute in Mumbai"],"prefix":"10.4103","volume":"54","author":[{"given":"Sanjith","family":"Saseedharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nausheen","family":"Shaffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Rambhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaijyanti","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240903","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R2-3-20240903","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/ejhpharm-2020-002226","article-title":"WHO raises concerns about lack of new antibiotics","volume":"27","author":"Kohl","year":"2020","journal-title":"Eur J Hosp Pharm"},{"key":"R3-3-20240903","doi-asserted-by":"crossref","first-page":"e026072","DOI":"10.1136\/bmjopen-2018-026072","article-title":"Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010-2016: A retrospective observational study","volume":"9","author":"Wang","year":"2019","journal-title":"BMJ Open"},{"key":"R4-3-20240903","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jiph.2017.08.008","article-title":"Benchmarking of antibiotic usage: An adjustment to reflect antibiotic stewardship program outcome in a hospital in Saudi Arabia","volume":"11","author":"Momattin","year":"2018","journal-title":"J Infect Public Health"},{"key":"R5-3-20240903","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40506-014-0015-3","article-title":"Antimicrobial Stewardship Programs: Appropriate Measures and Metrics to Study their Impact","volume":"6","author":"Morris","year":"2014","journal-title":"Curr Treat Options Infect Diseases"},{"key":"R6-3-20240903","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-019-0471-0","article-title":"Value of hospital antimicrobial stewardship programs [ASPs]: A systematic review","volume":"8","author":"Nathwani","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"R9-3-20240903","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/viru.21657","article-title":"Impact of formulary restriction with prior authorization by an antimicrobial stewardship program","volume":"4","author":"Reed","year":"2013","journal-title":"Virulence"},{"key":"R10-3-20240903","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4161\/viru.21626","article-title":"Antimicrobial stewardship: A review of prospective audit and feedback systems and an objective evaluation of outcomes","volume":"4","author":"Chung","year":"2013","journal-title":"Virulence"},{"key":"R11-3-20240903","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0213-005X(13)70134-4","article-title":"Scientific evidence and research in antimicrobial stewardship","volume":"31","author":"Almirante","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R12-3-20240903","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/dkn275","article-title":"Correlation between case mix index and antibiotic use in hospitals","volume":"62","author":"Kuster","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R13-3-20240903","doi-asserted-by":"crossref","first-page":"e01608","DOI":"10.1128\/JCM.01608-18","article-title":"The search for a practical method for colistin susceptibility testing: Have we found it by going back to the future?","volume":"57","author":"Satlin","year":"2019","journal-title":"J Clin Microbiol"},{"key":"R14-3-20240903","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijantimicag.2018.10.010","article-title":"Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection","volume":"53","author":"Medeiros","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"R15-3-20240903","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2147\/IDR.S172137","article-title":"Synergy effect of meropenem-based combinations against Acinetobacter baumannii: A systematic review and meta-analysis","volume":"11","author":"Jiang","year":"2018","journal-title":"Infect Drug Resist"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_466_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:47:53Z","timestamp":1787770073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_466_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_466_20","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}